Is Ketamine Therapy Legal in New Jersey?

If you're a New Jersey resident looking into at-home ketamine therapy, the first question you probably want answered is whether this is legal. It's a fair question: ketamine is a controlled substance, the at-home model is newer than the in-clinic model, and the federal rules around telehealth prescribing of controlled substances have been changing in recent years. Asking "is this legitimate?" is exactly the question I'd want answered before trusting any practice with a prescription.

The short answer: yes, ketamine therapy prescribed by a licensed clinician for depression, anxiety, PTSD, or chronic pain is legal in New Jersey. The longer answer is worth understanding so you can evaluate not just my answer but anyone else's claims.

How New Jersey treats ketamine

Ketamine is a Schedule III controlled substance under both federal and New Jersey state law. Schedule III is the category for medications with accepted medical use and a moderate-to-low dependence potential, distinct from Schedule I (no accepted medical use, like LSD) and Schedule II (stricter prescribing limits, like oxycodone or amphetamines). Schedule III medications can be prescribed by licensed practitioners through standard prescribing processes; no special license, no separate certification.

What this means practically: any New Jersey-licensed physician with an active DEA registration can prescribe ketamine. The use of ketamine for depression and other mental health conditions is off-label; the FDA approved ketamine for anesthesia, and prescribing it for psychiatric purposes falls under physician clinical judgment rather than a specific FDA indication. Off-label prescribing isn't a workaround; it's standard medical practice and accounts for somewhere around 20% of all U.S. prescriptions. The majority of psychiatric medications are used off-label for at least some of their indications.

How telehealth fits into the picture

New Jersey has a relatively progressive telehealth framework, established under the New Jersey Telemedicine and Telehealth Act and refined through subsequent regulatory guidance. The provisions relevant to ketamine therapy are:

A practitioner-patient relationship can be established via telehealth: your initial evaluation can occur through video consultation rather than requiring an in-person office visit.

Telehealth providers are held to the same standard of care as in-person providers. The clinical evaluation, the prescribing decisions, the ongoing monitoring; all must meet the same standard regardless of the delivery method. A physician who cuts corners by video is committing the same violation as one who cuts corners in person.

New Jersey-licensed practitioners can prescribe medications, including controlled substances, based on telehealth evaluations when clinically appropriate and consistent with federal regulations.

Ongoing monitoring and follow-up can also be conducted via telehealth, which is what makes long-term treatment relationships practical for patients who'd otherwise have to travel for every visit.

Tovani Health clinicians treating New Jersey patients hold active New Jersey medical licenses and operate within these state requirements.

The federal layer: the Ryan Haight Act

The federal law most relevant to telehealth-based prescribing of controlled substances is the Ryan Haight Online Pharmacy Consumer Protection Act, enacted in 2008 in response to internet pill mills that were dispensing controlled substances without legitimate medical oversight.

Under Ryan Haight, prescribing a controlled substance via telehealth historically required at least one in-person medical evaluation, or the prescription had to be issued by a practitioner working within a defined exception. That requirement was significantly relaxed during COVID, when the DEA issued temporary rules allowing controlled substance prescribing via telehealth without a prior in-person visit. Those flexibilities have been extended several times.

The DEA is in the process of finalizing permanent telehealth prescribing rules. The shape those rules take continues to evolve; there have been multiple proposed-rule cycles, and more are likely. Reputable practices structure their prescribing protocols to comply with both the current federal framework and applicable state requirements, and they update those protocols as the rules develop. We do that. Anyone serious about staying in business legitimately does that.

What this means for you as a patient: you're not the one who needs to track DEA rulemaking. The provider you choose is. Your job is to choose a provider whose compliance posture you trust. Which gets us to:

How to evaluate a provider

Now that you have the framework, here's what I'd look for if I were the patient.

A legitimate provider's prescribing clinicians hold active, unrestricted licenses in your state (meaning, for you in New Jersey, an actual NJ medical license, not just "we operate in NJ"). Their evaluation process is real: a synchronous video visit with a physician (or appropriately supervised mid-level provider, depending on the service) where they review your psychiatric history, current medications, medical conditions, substance use history, and contraindications. They say no to patients who aren't appropriate candidates. They use state-licensed pharmacies. They have an ongoing monitoring structure, not just a one-time prescription.

The signs that something is off: no live consultation before they prescribe, won't tell you their clinicians' credentials, vague about which pharmacy fills your prescription, no follow-up after the medication ships, a sales pitch that tells you you're a great candidate before any actual evaluation has happened. These aren't subtle; they're the same patterns that show up in healthcare practices that get into trouble in any specialty.

In-clinic vs. at-home in New Jersey

New Jersey has both models. In-clinic ketamine typically means IV infusions in a medical office, where you travel to the clinic, receive a 40-minute infusion, get monitored on-site for an hour or two, and then are driven home. The model offers in-room medical supervision; the cost is travel and time, plus higher per-session fees.

At-home ketamine therapy means sublingual ketamine you take at home with a sober adult sitter present, while a physician is reachable by phone. The model offers convenience, comfort, and lower cost; it requires you to bring discipline (the sitter, the prepared room, the day blocked off) and to fit the screening criteria for at-home administration, which are typically stricter than in-clinic criteria because the safety net is further away.

Both models are legal in New Jersey. Both have evidence supporting effectiveness. Which one fits you depends on your medical situation, your geography, your schedule, and your preference. (I've written more about this in At-Home vs. Clinic Ketamine: How I Help Patients Choose.)

A note about other psychedelic therapies

Patients sometimes ask whether ketamine is similar to other psychedelic-assisted treatments they've heard about. Legally, ketamine is unique among substances in this conversation. It's the one psychedelic-class medication with a well-established legal framework for therapeutic use: Schedule III, decades of clinical history, clear regulatory pathways.

The others aren't yet in the same place. Psilocybin (the active compound in psychedelic mushrooms) isn't legal for therapeutic use in New Jersey at this writing. Some other jurisdictions have decriminalized or created therapeutic frameworks; New Jersey hasn't. MDMA is similarly not approved for therapeutic use outside specific research settings (though it's been moving through clinical trials for PTSD). LSD and other Schedule I psychedelics remain prohibited for medical use.

This isn't a value judgment about whether those treatments should be available; it's just the legal status today. Ketamine is the one currently available through standard prescribing.

Your rights as a patient

A few things you're entitled to from any practice prescribing ketamine in New Jersey:

A thorough medical evaluation before treatment. Informed consent, with a clear explanation of risks, benefits, and alternatives. Privacy and confidentiality under HIPAA. The ability to contact your prescribing clinician with questions or concerns between sessions. The ability to discontinue treatment at any time. The ability to obtain copies of your medical records.

These aren't luxuries; they're the floor. If a practice doesn't provide them, find a different practice.

Where this leaves you

Ketamine therapy is legal in New Jersey, regulated under both state and federal frameworks, and supported by clinical evidence for treatment-resistant depression, anxiety, PTSD, and chronic pain. The legal landscape is well-established, the at-home model is workable for the right patients, and the only real questions for you are clinical and personal, not legal.

Frequently Asked Questions

Is ketamine therapy legal in New Jersey?

Yes, fully legal when prescribed by a New Jersey-licensed clinician for legitimate medical purposes. Ketamine is a federally Schedule III controlled substance, meaning it has accepted medical use and is legal to prescribe by registered clinicians. NJ-licensed physicians can legally prescribe it off-label for depression, anxiety, PTSD, and chronic pain (off-label prescribing is legal and routine in psychiatry). Medication is dispensed by a state-permitted compounding pharmacy. None of this is a gray area.

Does the Ryan Haight Act prevent telehealth ketamine prescribing in NJ?

No, there are explicit exceptions. The Ryan Haight Act generally requires an in-person evaluation before a controlled substance can be prescribed, but it includes exceptions for telehealth practice when a valid physician-patient relationship has been established via real-time video evaluation. DEA telehealth flexibilities introduced during COVID-19 have been extended through end of 2025, with rulemaking ongoing for permanent telehealth controlled-substance prescribing. Tovani Health complies with the current DEA framework and updates compliance as rules evolve.

How do I verify a New Jersey ketamine therapy provider is legitimate?

Verify these things. (1) Active NJ medical license, searchable at the New Jersey Division of Consumer Affairs license verification system. (2) The practice conducts a real eligibility evaluation including medical and psychiatric history. (3) Medication is dispensed by a US-licensed compounding pharmacy with verifiable address. (4) Initial consultation is a real-time video visit with the physician, not chat-only or asynchronous-only. (5) Cost transparency. Red flags: "no doctor visit needed," foreign pharmacies, vague provider identification, no eligibility screening.

Can a Florida-licensed physician treat me in New Jersey, or vice versa?

No, state medical licensure is separate. To treat a patient in New Jersey, the prescribing physician must hold an active New Jersey medical license; to treat a patient in Florida, an active Florida license. Tovani Health's prescribing physician is licensed in both states, so we treat patients in either state. If you cross state lines (e.g., Florida resident traveling in NJ for a few weeks), your provider must be licensed in whichever state you're physically in during the consultation and treatment.

Curious whether ketamine therapy is right for you?

Tovani Health is a physician-led at-home ketamine therapy practice serving Florida and New Jersey. Our prescribing physician holds active medical licenses in both states. Our eligibility check is the entry point; it takes about five minutes, and the result is honest. Sometimes that's "yes, let's evaluate"; sometimes that's "no, here's why, and here's what might serve you better." Either answer is the right one when it's the true one.

Check your eligibility →

Questions about credentials, compliance, or whether you specifically might be a candidate? Call 561-468-6981.

Benjamin Soffer, DO — Tovani Health

---

Related reading: how telehealth ketamine works in NJ, is ketamine therapy legal in Florida?, safety protocols, cost breakdown.